Work

Ustekinumab versus vedolizumab and ustekinumab versus tumor necrosis factor alpha agent infectious adverse effects in patients with ulcerative colitis, a real-world data study

Year: 2025

Type: article

Study design: Observational Study

Source: Expert Opinion on Pharmacotherapy

DOI: 10.1080/14656566.2025.2564333

Authors: Hussam Almasri, Abdellatif Ismail, Himsikhar Khataniar, Muhammad Ali Butt, Rahul Karna, John Bassett, Daphne Moutsoglou

Institutions: University of North Dakota, University of Maryland, College Park, Allegheny General Hospital, University of Minnesota, Sanford Health, Minneapolis VA Medical Center

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4414328010

FWCI: 0.535

Cites: 19

Cited by: 1

Related to: